TARPEYO (budesonide) delayed release capsules, FDA Approved to Reduce Proteinuria in IgA Nephropathy, Available Exclusively at Biologics by McKesson
CARY, N.C., Dec. 22, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]
Carcinoid Cancer Foundation Q&A
The Carcinoid Cancer Foundation’s mission is to increase awareness and education among the general public and healthcare providers about neuroendocrine tumors (NETs), to support NET cancer patients and their loved ones, and to serve as patient advocates. There are at least 175,000 people living with NETs in the United States.
Video Transcript: How to get your patients to actually follow your recommendations
Briana Contreras: All right. We will get started. Hello, everyone. Welcome to today’s live broadcast, How to Get Patients to […]
BESREMi (ropeginterferon alfa-2b-njft), FDA Approved for Treatment of Polycythemia Vera, Available at Biologics by McKesson
CARY, N.C., Dec. 6, 2021 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was […]
Newly Approved LIVTENCITY (maribavir) Now Available at Biologics by McKesson
CARY, N.C., Dec. 3, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]